Cardinal Health extends CVS deal through 2032, trades 9.6% below target
Alpha Vantage · ad-hoc-news.de · · AI-summarised by FinFlash
Cardinal Health has extended its pharmaceutical distribution agreement with CVS Health through June 30, 2032. The company also reaffirmed its fiscal 2027 non-GAAP earnings-per-share guidance of USD 12.40 to USD 12.60. Cardinal Health stock was trading at EUR 222.75 in weekend trading on October 24, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.